Baker’s yeast might not always be good for everyone – a case of percutaneous gastrostomy tube induced Saccharomyces cerevisiae peritonitis in an immunocompromised patient
  • Mohammad Kloub
    Saint Michael's Medical Center
  • Muhammad Hussain
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Michael’s Medical Center, Newark, USA
  • Fnu Marium
    Jinnah Sindh Medical University, Karachi, Pakistan
  • Atheer Anwar
    General Physician
  • Ahmad Haddad
    Department of Internal Medicine, Saint Michael’s Medical Center, Newark, USA
  • Jihad Slim
    Department of Infectious Disease, Saint Michael’s Medical Center, Newark, USA
  • Yatinder Bains
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Michael’s Medical Center, Newark, USA

Keywords

Percutaneous gastrostomy tube, Saccharomyces cerevisiae, peritonitis, HIV

Abstract

Peritonitis, the inflammation of the protective membrane surrounding parts of the abdominal organs, is a common clinical pathology with multifactorial aetiologies. While bacterial infections are well-recognised as a cause of peritonitis, fungal infections remain relatively uncommon especially Saccharomyces cerevisiae, which is commonly used for breadmaking and as a nutritional supplement. This fungus has been reported to induce peritonitis in patients on peritoneal dialysis. However, it has never been reported as secondary to percutaneous endoscopic gastrostomy (PEG) tube insertion in immunocompromised patients. We present a 64-year-old female with a history of human immunodeficiency virus (HIV) who developed S. cerevisiae peritonitis following PEG tube insertion. The case highlights the importance of considering rare organisms when treating immunocompromised patients with peritonitis, especially after gastrointestinal tract penetration or peritoneal membrane disruption.

VIEW THE ENTIRE ARTICLE

References

  • Swann H, Hughes D. Diagnosis and management of peritonitis. Vet Clin North Am Small Anim Pract 2000;30:603–615.
  • Duina AA, Miller ME, Keeney JB. Budding yeast for budding geneticists: a primer on the Saccharomyces cerevisiae model system. Genetics 2014;197:33–48.
  • Bouza E, Munoz P. Saccharomyces cerevisiae: the end of the innocence. Rev Esp Quimioter 2004;17:227-231.
  • Kiehn TE, Edwards FF, Armstrong D. The prevalence of yeasts in clinical specimens from cancer patients. Am J Clin Pathol 1980;73:518-521.
  • Wombwell E, Bransteitter B, Gillen LR. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic. Mycoses 2021;64:1521–1526.
  • Dougherty SH, Simmons RL. Postoperative peritonitis caused by Saccharomyces cerevisiae. Arch Surg 1982;117:248.
  • Hamoud S, Keidar Z, Hayek T. Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient. Isr Med Assoc J 2011;13:575–576.
  • Perez-Torrado R, Querol A. Saccharomyces cerevisiae show low levels of traversal across human endothelial barrier in vitro. F1000Res 2017;6:944.
  • Yoshida M, Obayashi T, Iwama A, Ito M, Tsunoda S, Suzuki T, et al. Detection of plasma (1-3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol 1997;35:371–374.
  • Popiel KY, Wong P, Lee MJ, Langelier M, Sheppard DC, Vinh DC. Invasive Saccharomyces cerevisiae in a liver transplant patient: case report and review of infection in transplant recipients. Transpl Infect Dis 2015;17:435–441.
  • Gomila Sard B, Téllez-Castillo CJ, García Pérez H, Moreno Munoz R. [Peritonitis caused by Saccharomyces cerevisiae in an ambulatory peritoneal dialysis patient]. Nefrología (English Edition) 2009;29:371–372

    • Views: 138
    HTML downloads: 17
    PDF downloads: 71

    Published: 2024-03-01
    Issue: 2024: Vol 11 No 4 (view)

    How to cite:
    1.
    Kloub M, Hussain M, Marium F, Anwar A, Haddad A, Slim J, Bains Y. Baker’s yeast might not always be good for everyone – a case of percutaneous gastrostomy tube induced Saccharomyces cerevisiae peritonitis in an immunocompromised patient. EJCRIM 2024;11 doi:10.12890/2024_004354.

    Most read articles by the same author(s)